Hi @Wilba32 ! Thought I'd jump on this sleuthing run..
Looking through the clinicaltrials.gov site searching 'COVID-19' and 'NIH', it spat out 71 replies.
Parsing through the search, I was looking for any NIH involvement, whether as a sponsor or study-support, and it yielded some interesting results.
1. The HCQ study in the Philippines was withdrawn (effective 9 Nov)
2. There's a B and T-cell repertoire and immune response study (not a treatment, just an investigation)
3. There's a P2 RCT trial looking at Fostamatinib (an SYK inhibitor - basically it inhibits pro-inflammatory cytokines by monocytes and macrophages (similar to Rem-L's MOA in one facet, but I fail to see how its gonna address the need for anti-inflammatory cytokines that plays a role in stimulating regeneration in inflamed tissue - this is the big reason why we were seeing more light being shed on the 'long covid' patients, and why Rem-L, in our generation, needs to be approved precisely for the complete eradication of C-19 in even the recovered patients.), decreased production of neutrophil extracellular traps (NETs) by neutrophils, and inhibition of platelet aggregation; three pathways that are mediated through Fc receptors (FcR) recognition of antigen-antibody complexes or activation of c-type lectin receptors (CLEC)So to answer you, Rem-L's the only NIH one that's the most promising right now.
- Forums
- ASX - By Stock
- Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
Hi @Wilba32 ! Thought I'd jump on this sleuthing run..Looking...
-
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 94863 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 5000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 85863 | 1.125 |
8 | 142044 | 1.120 |
8 | 196927 | 1.115 |
16 | 394801 | 1.110 |
4 | 48412 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 5000 | 2 |
1.135 | 15000 | 2 |
1.140 | 37912 | 2 |
1.145 | 27912 | 2 |
1.150 | 55804 | 4 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |